Dermavant Sciences GmbH
🇨🇭Switzerland
- Country
- 🇨🇭Switzerland
- Ownership
- Subsidiary
- Established
- 2016-01-01
- Employees
- 251
- Market Cap
- -
- Website
- https://dermavant.com
Clinical Trials
4
Active:0
Completed:3
Trial Phases
2 Phases
Phase 1:1
Phase 2:3
Drug Approvals
2
CANADA:1
Drug Approvals
NDUVRA
CANADA
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Phase 2
3 (75.0%)Phase 1
1 (25.0%)Safety and Tolerability Study of Cerdulatinib Gel, 0.37% in Adults With Vitiligo
- First Posted Date
- 2019-09-25
- Last Posted Date
- 2020-11-24
- Lead Sponsor
- Dermavant Sciences GmbH
- Target Recruit Count
- 33
- Registration Number
- NCT04103060
- Locations
- 🇺🇸
Dermavant Investigational Site, Worcester, Massachusetts, United States
Open-Label Study of RVT-501 Topical Ointment in Pediatric Patients With Atopic Dermatitis
Phase 1
- Conditions
- Atopic Dermatitis
- Interventions
- Drug: RVT-501 0.5% topical ointment
- First Posted Date
- 2018-01-30
- Last Posted Date
- 2018-05-11
- Lead Sponsor
- Dermavant Sciences GmbH
- Target Recruit Count
- 24
- Registration Number
- NCT03415282
- Locations
- 🇺🇸
Dermavant Investigational Site, Richmond, Virginia, United States
Study of RVT-501 Topical Ointment in Pediatric Patients With Atopic Dermatitis
Phase 2
Completed
- Conditions
- Atopic Dermatitis
- Interventions
- Drug: Vehicle ointmentDrug: RVT-501 0.5% ointment
- First Posted Date
- 2018-01-09
- Last Posted Date
- 2018-07-19
- Lead Sponsor
- Dermavant Sciences GmbH
- Target Recruit Count
- 110
- Registration Number
- NCT03394677
- Locations
- 🇨🇦
Dermavant Investigational Site, Montreal, Quebec, Canada
Study of RVT-501 in Adult and Adolescent Subjects With Atopic Dermatitis
Phase 2
Completed
- Conditions
- Atopic Dermatitis
- Interventions
- Drug: RVT-501 0.2% ointmentDrug: RVT-501 0.5% ointmentOther: Vehicle ointment
- First Posted Date
- 2016-11-01
- Last Posted Date
- 2018-08-06
- Lead Sponsor
- Dermavant Sciences GmbH
- Target Recruit Count
- 157
- Registration Number
- NCT02950922
- Locations
- 🇨🇦
Dermavant Investigator Site, Waterloo, Ontario, Canada
🇨🇦Dermavant Investigational Site, Montreal, Quebec, Canada
News
No news found